Ranjbaran Mina, Kadkhodaee Mehri, Seifi Behjat
Department of Physiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
J Nephropathol. 2017 Mar;6(2):69-73. doi: 10.15171/jnp.2017.12. Epub 2016 Nov 29.
Hemorrhagic shock (HS) is a condition produced by considerable loss of intravascular volume, which may eventually lead to organ damage and death.
In the present study, the potential implication of the kidney tissue tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-10 (IL-10) were evaluated in the protective effects of erythropoietin (EPO) during HS.
Male Wistar rats were randomized into three experimental groups; Sham, HS (hemorrhagic shock and resuscitation), and EPO (erythropoietin). HS was induced by 50% blood volume hemorrhage over 30 minutes. After 2 hours, resuscitation was performed within 30 minutes. In the EPO group, EPO (300 IU/kg, i.v.) was administered 10 minutes before HS induction. Urine was collected to determine urinary N-acetyl-β-D-glucosaminidase (NAG) activity level. The kidney cytokines (TNF-α, IL-6 and IL-10) mRNA expressions were measured by real-time polymerase chain reaction (PCR).
HS rats showed significant increase in urinary NAG activity compared to the sham group. EPO significantly attenuated the rises in urinary NAG activity compared to the HS group. In the HS animals, renal TNF-α and IL-6 mRNA expressions increased whereas no difference was observed in IL-10 mRNA expression between the HS and sham groups. EPO was able to decrease renal TNF-α and IL-6 production and increase IL-10 mRNA expression.
In this study, we demonstrated that EPO attenuates kidney damage in rats subjected to HS. The beneficial effects of EPO may be at least partly mediated by modifications in the inflammatory cascade.
失血性休克(HS)是一种因血管内大量失血而引发的病症,最终可能导致器官损伤和死亡。
在本研究中,评估了肾组织肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和白细胞介素-10(IL-10)在促红细胞生成素(EPO)对失血性休克的保护作用中的潜在影响。
将雄性Wistar大鼠随机分为三个实验组;假手术组、失血性休克组(失血性休克及复苏)和促红细胞生成素组(促红细胞生成素)。通过在30分钟内放血50%血容量诱导失血性休克。2小时后,在30分钟内进行复苏。在促红细胞生成素组中,在诱导失血性休克前10分钟静脉注射促红细胞生成素(300 IU/kg)。收集尿液以测定尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)活性水平。通过实时聚合酶链反应(PCR)测量肾细胞因子(TNF-α、IL-6和IL-10)mRNA表达。
与假手术组相比,失血性休克大鼠尿NAG活性显著增加。与失血性休克组相比,促红细胞生成素显著减轻了尿NAG活性的升高。在失血性休克动物中,肾TNF-α和IL-6 mRNA表达增加,而失血性休克组和假手术组之间的IL-10 mRNA表达未观察到差异。促红细胞生成素能够降低肾TNF-α和IL-6的产生,并增加IL-10 mRNA表达。
在本研究中,我们证明促红细胞生成素可减轻失血性休克大鼠的肾损伤。促红细胞生成素的有益作用可能至少部分是由炎症级联反应的改变介导的。